Altor BioScience: Attys Seek $1.65M Award For Altor-NantCell Deal In Del.

Chipman Brown Cicero & Cole LLP has asked the Delaware Chancery Court to approve a $1.65 million fee and expense award as part of a $5 million settlement that would end a shareholder suit over Altor Bioscience Corp.'s 2017 merger with billionaire physician Patrick Soon-Shiong's NantCell Inc.